Total Funding
81
38
Total FundingPost-IPO Debt raised
Growth Score
-14 pts
Heat Score
-29 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
200087
Implanet is a biotechnology company that provides implants for healthcare professionals treating orthopaedic patients.
Stéphane MILOT: VP Finance & Administration
Ludovic Lastennet: Founder and CEOPast Role: Stryker, European Sales Manager
About the Company
Implanet provide Gold Standard implants of uncompromising and indisputable quality to the various surgical markets. It is destined for healthcare professionals treating orthopedic patients. Implanet isa company that provides modern solutions (services, along with Gold Standard products) that allow healthcare professionals to improve their
productivity while contributing to society's urgent need to reduce healthcare costs. They believe that today, companies can evolve in the context of globalization while being socially and economically responsible. This organisation and business model provide an unprecedented level of security and information to the healthcare community.
